Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT06500689 |
| Consolidated Lead Sponsor | Shenzhen Salubris Pharmaceuticals Co |
| Therapeutic Condition Cohort | Cardiovascular and Thrombosis |
| Clinical Trial Phase | Phase III |
| Overall Recruitment Status | COMPLETED |
| Registered Enrollment | 366 participants (ACTUAL) |
| Registered Start Date | 2021-12-30 |
| WhyStopped Classification | Not Stopped |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| The First Affiliated Hospital of Bengbu Medical College | Bengbu, China | Open Hospital Dossier -> |
| China-Japan Friendship Hospital | Beijing, China | Open Hospital Dossier -> |
| The First Affiliated Hospital Of Fujian Medical University | Fuzhou, China | Open Hospital Dossier -> |
| The Fourth Hospital of Hebei Medical University | Shijiazhuang, China | Open Hospital Dossier -> |
Search related sites and sponsors in the Interactive Directory, explore Cardiovascular and Thrombosis Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.